Deutsche Bank’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.14M Buy
111,164
+45,469
+69% +$2.51M ﹤0.01% 1152
2025
Q1
$3.18M Sell
65,695
-72,237
-52% -$3.49M ﹤0.01% 1458
2024
Q4
$5.32M Buy
137,932
+17,763
+15% +$686K ﹤0.01% 1295
2024
Q3
$5.41M Sell
120,169
-788,179
-87% -$35.5M ﹤0.01% 1236
2024
Q2
$31.5M Sell
908,348
-2,458
-0.3% -$85.2K 0.01% 687
2024
Q1
$26.3M Buy
910,806
+794
+0.1% +$23K 0.01% 727
2023
Q4
$20.9M Buy
910,012
+838,099
+1,165% +$19.2M 0.01% 789
2023
Q3
$1.2M Sell
71,913
-789,411
-92% -$13.2M ﹤0.01% 1603
2023
Q2
$23.8M Sell
861,324
-97,567
-10% -$2.69M 0.01% 717
2023
Q1
$22.1M Buy
958,891
+33,229
+4% +$764K 0.01% 741
2022
Q4
$10.1M Buy
925,662
+113,307
+14% +$1.24M 0.01% 958
2022
Q3
$6.85M Sell
812,355
-5,477
-0.7% -$46.2K ﹤0.01% 1098
2022
Q2
$6.47M Sell
817,832
-4,491
-0.5% -$35.5K ﹤0.01% 1172
2022
Q1
$19.5M Sell
822,323
-2,549
-0.3% -$60.4K 0.01% 842
2021
Q4
$28.2M Buy
824,872
+1,582
+0.2% +$54.1K 0.01% 762
2021
Q3
$14.6M Buy
823,290
+1,568
+0.2% +$27.8K 0.01% 1007
2021
Q2
$36.9M Buy
821,722
+796,161
+3,115% +$35.7M 0.02% 698
2021
Q1
$662K Buy
25,561
+399
+2% +$10.3K ﹤0.01% 2896
2020
Q4
$507K Buy
25,162
+8,789
+54% +$177K ﹤0.01% 2869
2020
Q3
$320K Buy
16,373
+4,815
+42% +$94.1K ﹤0.01% 2902
2020
Q2
$205K Buy
11,558
+5,440
+89% +$96.5K ﹤0.01% 3091
2020
Q1
$43K Sell
6,118
-22,113
-78% -$155K ﹤0.01% 3542
2019
Q4
$197K Buy
28,231
+8,015
+40% +$55.9K ﹤0.01% 3186
2019
Q3
$241K Sell
20,216
-25,111
-55% -$299K ﹤0.01% 3042
2019
Q2
$548K Buy
45,327
+13,333
+42% +$161K ﹤0.01% 3194
2019
Q1
$401K Buy
31,994
+31,764
+13,810% +$398K ﹤0.01% 3525
2018
Q4
$1K Sell
230
-201,980
-100% -$878K ﹤0.01% 4618
2018
Q3
$2.08M Sell
202,210
-91,980
-31% -$947K ﹤0.01% 2811
2018
Q2
$1.98M Buy
294,190
+279,174
+1,859% +$1.88M ﹤0.01% 2949
2018
Q1
$128K Sell
15,016
-11,070
-42% -$94.4K ﹤0.01% 4237
2017
Q4
$541K Buy
26,086
+17,416
+201% +$361K ﹤0.01% 3476
2017
Q3
$152K Sell
8,670
-23,096
-73% -$405K ﹤0.01% 3848
2017
Q2
$358K Buy
31,766
+25,210
+385% +$284K ﹤0.01% 3528
2017
Q1
$83K Buy
6,556
+2,213
+51% +$28K ﹤0.01% 3789
2016
Q4
$94K Buy
4,343
+3,073
+242% +$66.5K ﹤0.01% 3900
2016
Q3
$26K Buy
+1,270
New +$26K ﹤0.01% 4125